
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the defense contractors industry, including General Dynamics (NYSE: GD) and its peers.
Defense contractors typically require technical expertise and government clearance. Companies in this sector can also enjoy long-term contracts with government bodies, leading to more predictable revenues. Combined, these factors create high barriers to entry and can lead to limited competition. Lately, geopolitical tensions–whether it be Russia’s invasion of Ukraine or China’s aggression towards Taiwan–highlight the need for defense spending. On the other hand, demand for these products can ebb and flow with defense budgets and even who is president, as different administrations can have vastly different ideas of how to allocate federal funds.
The 14 defense contractors stocks we track reported a strong Q3. As a group, revenues beat analysts’ consensus estimates by 3.4% while next quarter’s revenue guidance was in line.
Luckily, defense contractors stocks have performed well with share prices up 13.3% on average since the latest earnings results.
General Dynamics (NYSE: GD)
Creator of the famous M1 Abrahms tank, General Dynamics (NYSE: GD) develops aerospace, marine systems, combat systems, and information technology products.
General Dynamics reported revenues of $12.91 billion, up 10.6% year on year. This print exceeded analysts’ expectations by 3.1%. Overall, it was a very strong quarter for the company with an impressive beat of analysts’ backlog and revenue estimates.
"Each of our four segments grew earnings and backlog in the quarter, reflecting solid execution coupled with growing demand," said Phebe Novakovic, chairman and chief executive officer.

Interestingly, the stock is up 5.9% since reporting and currently trades at $361.53.
Is now the time to buy General Dynamics? Access our full analysis of the earnings results here, it’s free.
Best Q3: RTX (NYSE: RTX)
Originally focused on refrigeration technology, Raytheon (NSYE:RTX) provides a a variety of products and services to the aerospace and defense industries.
RTX reported revenues of $22.48 billion, up 11.9% year on year, outperforming analysts’ expectations by 5.4%. The business had a stunning quarter with a solid beat of analysts’ organic revenue estimates and an impressive beat of analysts’ EBITDA estimates.

The market seems happy with the results as the stock is up 20.6% since reporting. It currently trades at $194.15.
Is now the time to buy RTX? Access our full analysis of the earnings results here, it’s free.
Weakest Q3: AeroVironment (NASDAQ: AVAV)
Focused on the future of autonomous military combat, AeroVironment (NASDAQ: AVAV) specializes in advanced unmanned aircraft systems and electric vehicle charging solutions.
AeroVironment reported revenues of $472.5 million, up 151% year on year, exceeding analysts’ expectations by 0.5%. Still, it was a slower quarter as it posted a significant miss of analysts’ EBITDA estimates and a significant miss of analysts’ EPS estimates.
Interestingly, the stock is up 31.7% since the results and currently trades at $371.34.
Read our full analysis of AeroVironment’s results here.
Mercury Systems (NASDAQ: MRCY)
Founded in 1981, Mercury Systems (NASDAQ: MRCY) specializes in providing processing subsystems and components for primarily defense applications.
Mercury Systems reported revenues of $225.2 million, up 10.2% year on year. This number beat analysts’ expectations by 9.5%. It was an exceptional quarter as it also logged a solid beat of analysts’ organic revenue estimates and a beat of analysts’ EPS estimates.
Mercury Systems achieved the biggest analyst estimates beat among its peers. The stock is up 28.3% since reporting and currently trades at $97.10.
Read our full, actionable report on Mercury Systems here, it’s free.
Leidos (NYSE: LDOS)
Formed through the split of IT services company SAIC, Leidos (NYSE: LDOS) offers technology and engineering solutions such as military training systems for the defense, civil, and health markets.
Leidos reported revenues of $4.47 billion, up 6.7% year on year. This print topped analysts’ expectations by 4.1%. Overall, it was an exceptional quarter as it also recorded a solid beat of analysts’ backlog estimates and an impressive beat of analysts’ EBITDA estimates.
The stock is flat since reporting and currently trades at $194.56.
Read our full, actionable report on Leidos here, it’s free.
Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.
StockStory’s analyst team — all seasoned professional investors — uses quantitative analysis and automation to deliver market-beating insights faster and with higher quality.